These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19031214)

  • 1. Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.
    Al-Azzawi F
    Gynecol Endocrinol; 2008 Nov; 24(11):601-9. PubMed ID: 19031214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
    Kastelan D; Vlak T
    Reumatizam; 2007; 54(2):87-8. PubMed ID: 18351153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postmenopausal osteoporosis].
    Miki T; Tamura A
    Nihon Rinsho; 2006 Jun; Suppl 2():81-6. PubMed ID: 16817356
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 8. Under-use of bisphosphonates in rural elderly women who have sustained fractures.
    Naunton M; Peterson G; Jones G
    Aust J Rural Health; 2006 Dec; 14(6):286. PubMed ID: 17121511
    [No Abstract]   [Full Text] [Related]  

  • 9. Who will benefit from antiresorptive treatment (bisphosphonates)?
    Papapoulos SE
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring aging bones.
    Rosen CJ
    Sci Am; 2003 Mar; 288(3):70-7. PubMed ID: 12616861
    [No Abstract]   [Full Text] [Related]  

  • 11. When do bisphosphonates make the most sense?
    Winzenberg T; Jones G
    J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of osteoporosis-related fractures among postmenopausal women and older men.
    Rahmani P; Morin S
    CMAJ; 2009 Nov; 181(11):815-20. PubMed ID: 19841053
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention for the older woman. A practical guide to prevention and treatment of osteoporosis.
    Messinger-Rapport BJ; Thacker HL
    Geriatrics; 2002 Apr; 57(4):16-8, 21-4, 27. PubMed ID: 11974387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 May; 374(21):2096-7. PubMed ID: 27223157
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal Osteoporosis.
    Michaëlsson K; Aspenberg P
    N Engl J Med; 2016 May; 374(21):2095. PubMed ID: 27223158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.